Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.

MLA

Jeyam, Anita, et al. “Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.” Diabetes Care, vol. 44, no. 2, Feb. 2021, pp. 390–98. EBSCOhost, https://doi.org/10.2337/dc20-0567.

APA

Jeyam, A., Colhoun, H., McGurnaghan, S., Blackbourn, L., McDonald, T. J., Palmer, C. N. A., McKnight, J. A., Strachan, M. W. J., Patrick, A. W., Chalmers, J., Lindsay, R. S., Petrie, J. R., Thekkepat, S., Collier, A., MacRury, S., & McKeigue, P. M. (2021). Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care, 44(2), 390–398. https://doi.org/10.2337/dc20-0567

Chicago

Jeyam, Anita, Helen Colhoun, Stuart McGurnaghan, Luke Blackbourn, Timothy J McDonald, Colin N A Palmer, John A McKnight, et al. 2021. “Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.” Diabetes Care 44 (2): 390–98. doi:10.2337/dc20-0567.